SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-15-008919
Filing Date
2015-02-13
Accepted
2015-02-13 14:27:11
Documents
1
Group Members
DON A. SANDERSJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND II (INSTITUTIONAL), L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLCSOF MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v401643_sc13da.htm SC 13D/A 161870
  Complete submission text file 0001144204-15-008919.txt   163768
Mailing Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223
Business Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 503-692-8001
BIOJECT MEDICAL TECHNOLOGIES INC (Subject) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40150 | Film No.: 15612792
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019
Business Address 152 W 57TH STREET 19TH FLOOR NEW YORK NY 10019 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A